Sun Life Financial Inc Dexcom Inc Transaction History

Sun Life Financial Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$80.99 - $107.93 $4,697 - $6,259	-58 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$84.79 - $104.74 $84 - $104	1 Added 1.75%	58 $21,000
Q4 2020 Feb 11, 2021	SELL	$78.0 - $104.5 $78 - $104	-1 Reduced 1.72%	57 $21,000
Q3 2020 Nov 09, 2020	BUY	$95.51 - $112.95 $286 - $338	3 Added 5.45%	58 $24,000
Q2 2020 Aug 12, 2020	BUY	$62.68 - $105.34 $3,447 - $5,793	55 New	55 $22,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Sun Life Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Sun Life Financial Inc with notifications on news.